hematology

Hematology

Anesthesiology (13)
Biomedicine (330)
Cardiology (42)
Dental care (21)
Dermatology (41)
Endocrinology (12)
Epidemiology (35)
Etiology (5)
Gynecology (14)
Hematology (17)
Medicine (1827)
Neurology (328)
Obstetrics (9)
Oncology (115)
Ophthalmology (52)
Orthopedics (51)
Pediatrics (142)
Preclinical (83)
Psychiatry (135)
Radiology (48)
Surgery (1295)
Toxicology (26)
Urology (27)

The researchers say that the new method could have wide applications not only in digital pathology but also in everything from hematology to wafer inspection to forensic photography.

and Lora S. Lurie Professor in Medicine-Hematology/Oncology and Biochemistry and Molecular genetics, and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

a pediatric hematologist/oncologist at Dana-Farber/Boston Children. ur goal was to break the enhancer,

and associate chief of hematology/oncology at Boston Children Hospital. t a very different approach to treating disease. he data provide proof of principle that targeted edits to BCL11A enhancer in blood stem cells could be an attractive approach

and young adults with rare blood disorders Hematology researchers have safely and effectively treated children and young adults for autoimmune blood disorders in a multicenter clinical trial.

"said study leader David T. Teachey, M d.,a physician-researcher in hematology and oncology at The Children's Hospital of Philadelphia (CHOP)."

according to a study published online today in Blood, the Journal of the American Society of Hematology (ASH).

Professor of Hematology/Oncology at the University of Chicago, there are just not enough players in the generic specialty drug market that have the capability to manufacture these drugs.

and an associate professor in the Division of Hematology-Oncology at the U-M Medical school.""Leukemia is a cancer of the body's blood-forming tissues,

drugs that are approved currently for treatment of other hematologic cancers such as polycythemia vera and myelofibrosis."

The new data which builds on preliminary findings presented at the American Society of Hematology's annual meeting in December 2013 include results from the first 25 children and young adults (ages 5 to 22

whose specialties range from hematology to immunology surface chemistry and materials science. This really could only happen in a place like the Wyss Institute Ingber said.

and an associate professor of medicine in the division of hematology and oncology at the David Geffen School of medicine at UCLA. Kitchen and his colleagues were the first to report the use of an engineered molecule called a chimeric antigen receptor,

The study first author was Anjie Zhen, a postdoctoral fellow at UCLA in the Division of Hematology/Oncology, the UCLA AIDS Institute and the Broad Stem Cell Research center.

#Wall street journal Highlights Promising Gene therapy Advances Yesterday, bluebird bio reported some very uplifting news at the annual meeting of the American Society of Hematology.

Alexis A. Thompson, head of hematology at Northwestern University Feinberg School of medicine in Chicago, and lead investigator of the study. n a relatively short period of time,

as well as the Asa and Patricia Shiverick-Jane Shiverick (Tripp) Professor of Hematological Oncology. Case Western Reserve research associate Amar Desai, Phd, worked between the Markowitz